Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Aurora Cannabis Inc.

Aurora Cannabis Inc. (ACB) Stock Overview

Explore Aurora Cannabis Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACB●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$3.89
$0.14(3.47%)
U.S. Market opens in 7h 18m

Aurora Cannabis Inc. (ACB)

Meyka AI Score

Z

Key Financials

Market Cap241M
P/E Ratio-2.76
EPS (TTM)$-0.49
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$4.59
3 Months$2.09
1 Year Target$4.44

ACB Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Aurora Cannabis Inc. (NASDAQ: ACB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Aurora Cannabis Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACB on the NASDAQ shows an RSI of 62.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.44 for the NASDAQ listing.

Key metrics behind Aurora Cannabis Inc.'s NASDAQ-traded stock include a P/E ratio of -2.76 and a market capitalization of 241M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACB on the NASDAQ.

Price Performance (NASDAQ: ACB)

1-Day Change
-3.47%
5-Day Change
-2.26%
1-Month Change
37.46%
3-Month Change
13.74%
6-Month Change
11.78%
Year-to-Date (YTD) Change
-7.82%
1-Year Change
-20.77%
3-Year Change
-19.79%
5-Year Change
-94.74%
All-Time (Max) Change
-96.41%

Contact Information

https://www.auroramj.com
16043625207
90B Street SW, Edmonton, AB, T6X 1V8

Company Facts

10,280 Employees
IPO DateJul 15, 2014
CountryCA
Actively Trading

Frequently Asked Questions